Table 1.
The number of targets and pathways of XST and the major ingredients. The pathways represent the number of CVD-related pathways enriched by the all targets of XST or the major ingredients.
Targets | Pathways | |||
---|---|---|---|---|
All | Confirmed in CVD-related literatures | Confirmed in non CVD-related literatures | ||
XST | 70 | 32 | 38 | 18 |
Ginsenoside Rg1 | 49 | 17 | 32 | 15 |
Ginsenoside Rb1 | 36 | 12 | 24 | 12 |
Notoginsenoside R1 | 9 | 8 | 1 | 6 |
Ginsenoside Rd | 20 | 3 | 17 | 11 |
Ginsenoside Re | 18 | 2 | 16 | 10 |